- Home
- GWAV vs VRAX Comparison
GWAV vs VRAX Comparison
Compare GWAV & VRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GWAV
- VRAX
- Stock Information
- Founded
- GWAV 2002
- VRAX 2013
- Country
- GWAV United States
- VRAX United Kingdom
- Employees
- GWAV N/A
- VRAX N/A
- Industry
- GWAV Packaged Foods
- VRAX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- GWAV Consumer Staples
- VRAX Health Care
- Exchange
- GWAV Nasdaq
- VRAX Nasdaq
- Market Cap
- GWAV 3.7M
- VRAX 4.4M
- IPO Year
- GWAV N/A
- VRAX 2022
- Fundamental
- Price
- GWAV $8.17
- VRAX $0.66
- Analyst Decision
- GWAV
- VRAX Strong Buy
- Analyst Count
- GWAV 0
- VRAX 1
- Target Price
- GWAV N/A
- VRAX $3.00
- AVG Volume (30 Days)
- GWAV 92.7K
- VRAX 370.2K
- Earning Date
- GWAV 11-14-2025
- VRAX 01-01-0001
- Dividend Yield
- GWAV N/A
- VRAX N/A
- EPS Growth
- GWAV N/A
- VRAX N/A
- EPS
- GWAV N/A
- VRAX N/A
- Revenue
- GWAV $33,315,859.00
- VRAX $6,331.00
- Revenue This Year
- GWAV N/A
- VRAX $217,274.83
- Revenue Next Year
- GWAV N/A
- VRAX N/A
- P/E Ratio
- GWAV N/A
- VRAX N/A
- Revenue Growth
- GWAV N/A
- VRAX N/A
- 52 Week Low
- GWAV $6.02
- VRAX $0.52
- 52 Week High
- GWAV $119.90
- VRAX $3.62
- Technical
- Relative Strength Index (RSI)
- GWAV 63.79
- VRAX 51.02
- Support Level
- GWAV $6.41
- VRAX $0.61
- Resistance Level
- GWAV $8.74
- VRAX $0.69
- Average True Range (ATR)
- GWAV 0.70
- VRAX 0.03
- MACD
- GWAV -0.10
- VRAX 0.01
- Stochastic Oscillator
- GWAV 81.52
- VRAX 72.62
About GWAV Greenwave Technology Solutions Inc.
Greenwave Technology Solutions Inc through its subsidiary, is an operator of several metal recycling facilities in Virginia, Ohio and North Carolina. At these facilities, the company is involved in collecting, classifying, and processing raw scrap metal (ferrous and nonferrous) for recycling. The company involves collecting, classifying and processing appliances, construction material, end-of-life vehicles, boats, and industrial machinery and processing those items by crushing, shearing, shredding, separating, and sorting, into smaller pieces and categorize these recycled ferrous, nonferrous, and mixed metal pieces based on density and metal prior to sale.
About VRAX Virax Biolabs Group Limited
Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes (HSV-1) and Human Papillomavirus (HPV).